31Phosphorus magnetic resonance spectroscopy in schizophrenia research. On the pathophysiology of the cerebral high energy phosphate and membrane phospholipid metabolism;31Phosphor-magnetresonanz-spektroskopie in der schizophrenieforschung. Zur pathophysiologie des zerebralen stoffwechsels energiereicher phosphate und membranphospholipide

Nervenarzt

Volumn 71, Issue 5, 2000, Pages 354-363

  Riehemann, S ^a   Volz, H P ^a   Smesny, S ^a   Hübner, Gabriele ^a   Wenda, B ^a   Rößger, Grit ^a   Sauer, H ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

High energy phosphates; Magnetic resonance spectroscopy; Phospholipids; Schizophrenia

Indexed keywords

PHOSPHATE; PHOSPHOLIPID; PHOSPHORUS 31; ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; DIAGNOSTIC AGENT; PHOSPHORUS;

BRAIN METABOLISM; ENERGY METABOLISM; HUMAN; MENTAL DISEASE; PATHOPHYSIOLOGY; PHOSPHOLIPID METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; AGE; BRAIN; BRAIN LEVEL; CONTROLLED CLINICAL TRIAL; HEMISPHERIC DOMINANCE; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SEX DIFFERENCE;

ADENOSINE TRIPHOSPHATE; AGE FACTORS; BRAIN; BRAIN CHEMISTRY; CONTROLLED CLINICAL TRIALS; DOMINANCE, CEREBRAL; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHATES; PHOSPHOCREATINE; PHOSPHOLIPIDS; PHOSPHORUS RADIOISOTOPES; SCHIZOPHRENIA; SEX FACTORS;

EID: 0033625693     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050569     Document Type: Review

References (57)

1. Andreasen NC, Rezai K, Alliger R (1992) Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Arch Gen Psychiatry 49:943-958
2. 31P magnetic resonance spectroscopy study in vivo. Pediatric Research 35:431-435
3. 31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia. Biol Psychiatry 32:26-32
4. 31Phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia. Biol Psychiatry 36:503-510
5. Deicken RF, Merrin EL, Floyd TC, Weiner MW (1994b) Correlations between left frontal phospholipids and Wisconsin card sorting test performance in schizophrenia. Schizophr Res 14:177-181
6. Deicken RF, Calabrese G, Merrin EL, Fein G, Weiner MW (1995a) Basal ganglia phosphorous metabolism in chronic schizophrenia. Am J Psychiatry 152:126-129
7. Deicken RF, Calabrese G, Merrin EL, Vinogradov S, Fein G, Weiner MW (1995b) Asymmetry of temporal lobe phosphorus metabolism in schizophrenia: a 31-phosphorus magnetic resonance spectroscopic imaging study. Biol Psychiatry 38:279-286
8. DeLisi LE, Buchsbaum MS, Holcomb HH (1989) Increased temporal lobe glucose use in chronic schizophrenic patients. Biol Psychiatry 29:159-175
9. 31P magnetic resonance chemical shift imaging. Acta Psychiatr Scand 86:455-462
10. 31P magnetic resonance spectroscopy of the medial temporal lobe of schizophrenic patients with neuroleptic-resistant marked positive symptoms. Eur Arch Psych Clin Neurosci 244:236-240
11. Fukuzako H, Fukuzako T, Takeuchi K, Ohbo Y, Ueyama K, Takigawa M, Fujimoto T (1996) Phosphorus magnetic resonance spectroscopy in schizophrenia: correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms. Prog Neuropsychopharmacol Biol Psychiatry 20:629-640
12. Glonek T, Kopp SJ, Kot E, Pettegrew JW, Harrison WH, Cohen MM (1982) P-31 nuclear magnetic resonance analysis of brain. The perchloric acid extract spectrum. J Neurochem 39:1210-1219
13. Gur RE, Resnick SM, Alavi A (1987) Regional brain function in schizophrenia. I. A positron emission tomograph study. Arch Gen Psychiatry 44:119-125
14. Gur RE, Resnick SM, Gur RC (1989) Laterally and frontality of cerebral blood flow and metabolism in schizophrenia: relationship to symptom specifity. Psychiatry Res 27:325-334
15. Häfner H, Maurer K, Loffler W (1994) The epidemiology of early schizophrenia. Influence of age and gender on onset and early course. Br J Psychiatry [Suppl]23:29-38
16. Hinsberger AD, Williamson PC, Carr TJ (1997) Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia. J Psychiatry Neurosci 22:111-117
17. Horrobin DF (1996) Schizophrenia as a membran lipid disorder which is expressed throughout the body. Prostaglandins Leukot Essent Fatty Acids 55:3-7
18. Horrobin DF (1998) The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 30:193-208
19. 31P magnetoresonance-spectroscopic parameters in the frontal lobe of schizophrenics and healthy controls. Proc SPIE 3660:429-436
20. 31P-MRS of the frontal lobes in patients with schizophrenia. Proc Soc Magn Res 2:602
21. Kato T, Shioiri T, Murashita J, Hamakawa H, Inubushi T, Takahashi S (1995) Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia. Psychiatry Res Neuroimag 61:151-160
22. Keshavan MS, Kapur S, Pettegrew (1991) Magnetic resonance spectroscopy in psychiatry. Potential, pitfalls, and promise. Am J Psychiatry 148:976-985
23. 31P NMR spectrum of human brain: the determination of the concentrations of phosphodiester components. FEBS Lett 272:163-165
24. 31P MRS of the normal adult human brain. Assessment of interindividual differences and ageing effect. NMR Biomed 6:53-57
25. Miller DD, Rezai K, Alliger R, Andreasen NC (1997) The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography. Biol Psychiatry 41:550-559
26. 31P magnetic resonance spectroscopy of normal peripubertal children: effects of sex and fronto-occipetal location. Proc ISMRM 1408
27. 31P NMR spectra in vivo. MRM 12:282-289
28. 31P magnetic resonance spectroscopy. Biol Psychiatry 29:1149-1152
29. 31P nuclear magnetic resonance spectroscopy. Neurology 35:781-788
30. 31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developping and degenerating brain: Preliminary observations. J Neuropath Exp Neurol 46:419-430
31. Pettegrew JW, Panchalingam K, Withers G, McKeag D, Strycho S (1990) Changes in brain energy and phospholipid metabolism during development and aging in the Fischer 344 rat. J Neuropath Exp Neurol 49:237-249
32. Pettegrew JW, Keshavan MS, Panchalingam K, Strycho S, Kaplan DB, Tretta MG, Allen M (1991) Alterations in brain high-energy phosphate and membrane metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo Phosphorus 31 nuclear magnetic resonance spectroscopy. Arch Gen Psychiatry 48:563-568
33. Pettegrew JW (1991) Nuclear magnetic resonance: principles and applications to neuroscience research. In: Boller F, Grafman J (eds) Handbook of neuropsychology, Vol. 4. Elsevier, Amsterdam, 39-56
34. 31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia. Schizophr Bull 19:35-53
35. 1H decoupling. Proc ISMRM 998
36. 1H decoupling of medicated schizophrenics and healthy controls. Proc ISMRM 1413
37. Puri BK, Richardson AJ (1998) Sustained remission of positive and negative symptoms of schizophrenia following treatment with eicosapentaenoic acid. Arch Gen Psychiatry 55:188-189
38. Reiser M, Semmler W (1997) Magnetresonanztomographie. Springer, Berlin Heidelberg New York Tokyo
39. Riehemann S, Volz HP, Gaser C, Sauer H (1998) Phosphorous NMR in schizophrenia - the influence of different evaluation methods on spectral interpretation. Neuroimage 7 [Suppl]:621
40. 31P-MRS reveals gender differences in healthy controls, not in schizophrenics. NMR Biomed 12:483-489
41. 2. Arch Gen Psychiatry 54:487-494
42. Schröder J, Buchsbaum MS, Siegel BV, Geider FJ, Tang C, Wu J, Potkin SG (1996) Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia. Schizophr Res 19:41-53
43. Shioiri T, Kato T, Inubushi T, Murashita J, Takahashi S (1994) Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symtpoms in schizophrenia. Psychiatry Res 55:223-235
44. Shioiri T, Someya T, Murashita J, Kato T, Hamakawa H, Fujii K, Inubushi T (1997) Multiple regression analysis of relationship between frontal lobe phosphorus metabolism and clinical symptoms in patients with schizophrenia. Psychiatry Res: Neuroimaging 76:113-122
45. 31P-MR spectroscopy study. Schizophr Res 13:209-215
46. Stanley JA, Williamson PC, Drost DJ, Carr TJ, Rylett J, Malla A, Thomson RT (1995) An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch Gen Psychiatry 52:399-406
47. van der Knaap MS, van der Grond J, van Rijen PC, Faber JAJ Valk J, Willemse K (1990) Age dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology 176:509-515
48. 31P magnetic resonance spectroscopy in the dorsolateral prefrontal cortex of schizophrenics with a volume selective technique - preliminary findings. Biol Psychiatry 41:644-648
49. Volz HP, Gaser C, Häger F, Rzanny R, Mentzel HJ, Kreitschmann-Andermahr I, Kaiser WA, Sauer H (1997b) Brain activation during cognitive stimulation with the Wisconsin Card Sorting Test - a functional MRI study of healthy volunteers and schizophrenics. Psychiatry Res Neuroimag 75:145-158
50. 31P-magneto-resonance-spectroscopic study. Psychiatry Res Neuroimag 76:123-129
51. 31phosphorus magnetic resonance spectroscopic and neuropsychological investigation. Schizophr Res 31:37-47
52. 31Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics - a study including 50 patients and 36 controls. Biol Psychiatry 44:399-404
53. 31P-magnetic resonance spectroscopy study. Biol Psychiatry 45:1221-1225
54. 31P-MRS parameters in the frontal lobes of healthy controls and schizophrenics. European Arch Psych Clin Neurosci 248 [Suppl 2]:137
55. Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669
56. Wicklow K, Kolem H, Schneider M, Sauter R (1993) Klinische Magnetresonanzspektroskopie: Möglichkeiten und Methoden an Ganzkörpertomographen. Akt Radiol 3:90-99
57. Williamson P, Drost D, Stanley J, Carr T, Morrison S, Merskey H (1991) Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls (letter). Arch Gen Psychiatry 48:578